Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA)
- PMID: 17710551
- DOI: 10.1007/s10620-007-9895-0
Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA)
Abstract
A primary obstacle to early diagnosis and treatment of hepatic encephalopathy (HE) is the lack of a well-validated, standardized assessment method. The purpose of this study was to present preliminary validity data on a new method of grading HE, the Hepatic Encephalopathy Scoring Algorithm (HESA), which combines clinical impressions with neuropsychological performances to characterize HE. Participants were 49 inpatients admitted for complications of end stage liver disease. Each participant's level of HE was graded using HESA and the West Haven Criteria (WHC) by independent raters blinded to each other's rating. A moderately strong association was found between the two grading methods (r = 0.60), and individual HESA clinical and neuropsychological indicators were good discriminators among grades. The results also suggest HESA may be more sensitive to mental status impairment in the middle grades of HE than WHC. These findings suggest HESA holds promise as a multi-method approach to grading all levels of HE.
Similar articles
-
Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy.Am J Gastroenterol. 2009 Jun;104(6):1392-400. doi: 10.1038/ajg.2009.160. Am J Gastroenterol. 2009. PMID: 19455117 Clinical Trial.
-
Relationship between clock and star drawing and the degree of hepatic encephalopathy.Postgrad Med J. 2011 Sep;87(1031):605-11. doi: 10.1136/pgmj.2010.108985. Epub 2011 Jun 21. Postgrad Med J. 2011. PMID: 21693571
-
Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles.Drugs. 2019 Feb;79(Suppl 1):5-9. doi: 10.1007/s40265-018-1018-z. Drugs. 2019. PMID: 30706420 Free PMC article. Review.
-
Modified-orientation log to assess hepatic encephalopathy.Aliment Pharmacol Ther. 2012 Apr;35(8):913-20. doi: 10.1111/j.1365-2036.2012.05038.x. Epub 2012 Feb 21. Aliment Pharmacol Ther. 2012. PMID: 22348593 Free PMC article.
-
Assessment and usefulness of clinical scales for semiquantification of overt hepatic encephalopathy.Clin Liver Dis. 2012 Feb;16(1):27-42. doi: 10.1016/j.cld.2011.12.005. Clin Liver Dis. 2012. PMID: 22321463 Review.
Cited by
-
Challenges in diagnosing hepatic encephalopathy.Neurochem Res. 2015 Feb;40(2):265-73. doi: 10.1007/s11064-014-1416-x. Epub 2014 Aug 21. Neurochem Res. 2015. PMID: 25142937 Review.
-
Polyethylene glycol versus lactulose in the treatment of hepatic encephalopathy: a systematic review and meta-analysis.BMJ Open Gastroenterol. 2021 May;8(1):e000648. doi: 10.1136/bmjgast-2021-000648. BMJ Open Gastroenterol. 2021. PMID: 34006606 Free PMC article.
-
Overt hepatic encephalopathy: development of a novel clinician reported outcome tool and electronic caregiver diary.Metab Brain Dis. 2016 Oct;31(5):1081-93. doi: 10.1007/s11011-016-9851-9. Epub 2016 Jun 9. Metab Brain Dis. 2016. PMID: 27278222
-
Use of bispectral index monitoring for a patient with hepatic encephalopathy requiring living donor liver transplantation: a case report.J Anesth. 2011 Feb;25(1):117-9. doi: 10.1007/s00540-010-1055-6. Epub 2010 Dec 3. J Anesth. 2011. PMID: 21127916
-
Hepatic encephalopathy.Gastroenterol Rep (Oxf). 2017 May;5(2):138-147. doi: 10.1093/gastro/gox013. Epub 2017 Apr 18. Gastroenterol Rep (Oxf). 2017. PMID: 28533911 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical